Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry.

Synthetic cannabinoids are a group of compounds that are structurally diverse and are commonly found in various herbal incense and potpourri blends, which are sold in convenience stores, smoke shops and over the Internet. During the past few years, multiple state and federal legislations have been enacted controlling various subsets of these compounds that have been detected in compound categories generally considered the first and second product generations. As shown in previous studies, as compounds become controlled, new compounds emerge and become prevalent. We report on the emergence and prevalence of five different compounds (A796,260, MAM-2201, UR-144, URB597 and XLR-11) in the state of Indiana through their qualitative detection in solid-dosage herbal products via rapid solvent extraction and ultra-performance liquid chromatography with time-of-flight mass spectrometry (UPLC/ToF). We demonstrate the use of UPLC/ToF to be a suitable tool in the identification of these substances in a crime laboratory or forensic laboratory setting, which ultimately enables a laboratory to design assays for the detection of specific analytes in biological specimens in regard to regional trends and prevalence.

[1]  A. Lichtman,et al.  Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation , 2009, The AAPS Journal.

[2]  Y. Goda,et al.  Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products , 2010, Forensic Toxicology.

[3]  T. Sobolevsky,et al.  Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. , 2012, Drug testing and analysis.

[4]  A. Duranti,et al.  The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3′-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice , 2007, Journal of Pharmacology and Experimental Therapeutics.

[5]  Ming-Jung Wu,et al.  3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. , 2003, Bioorganic & medicinal chemistry.

[6]  P. Chandran,et al.  Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. , 2010, Journal of medicinal chemistry.

[7]  P. Chandran,et al.  In vitro and in vivo characterization of A‐796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models , 2008, British journal of pharmacology.

[8]  J. Ramsey,et al.  Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. , 2010, Journal of analytical toxicology.

[9]  B. Logan,et al.  Identification of Synthetic Cannabinoids in Herbal Incense Blends in the United States , 2012, Journal of forensic sciences.

[10]  H. Schiebel,et al.  Analysis of synthetic cannabinoids in “spice-like” herbal highs: snapshot of the German market in summer 2011 , 2012, Analytical and Bioanalytical Chemistry.

[11]  Y. Goda,et al.  URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. , 2013, Forensic science international.

[12]  Daniele Piomelli,et al.  Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). , 2006, CNS drug reviews.

[13]  G. Behonick,et al.  Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. , 2012, Journal of analytical toxicology.

[14]  A. Duranti,et al.  The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues. , 2006, Pharmacological research.

[15]  I. Mikhura,et al.  UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products. , 2013, Drug testing and analysis.

[16]  B. Cravatt,et al.  Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. , 2005, Chemistry & biology.

[17]  D. Piomelli,et al.  The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport , 2007, Journal of Pharmacology and Experimental Therapeutics.

[18]  G. Hynd,et al.  Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. , 2005, Bioorganic & medicinal chemistry.